March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Outcomes of Epithelium-On Crosslinking in Older Adults
Author Affiliations & Notes
  • William Trattler
    Cornea, Center For Excellence in Eye Care, Miami, Florida
  • Roy Rubinfeld
    Washington Eye Physicians and Surgeons, Chevy Chase, Maryland
  • Gabriela Perez
    Ctr for Excellence in Eye Care, Miami, Florida
  • John Talamo
    Talamo Laser Consultants, Waltham, Massachusetts
  • Kathryn M. Hatch
    Talamo Laser Consultants, Waltham, Massachusetts
  • Jodi Luchs
    Southshore Eye Care, Wantagh, New York
  • Gaston Lacayo
    Cornea, Center For Excellence in Eye Care, Miami, Florida
  • Gregg Berdy
    The Cornea and Laser Vision Institute, St. Louis, Missouri
  • Footnotes
    Commercial Relationships  William Trattler, CXLUSA (C); Roy Rubinfeld, CXLUSA (E); Gabriela Perez, None; John Talamo, None; Kathryn M. Hatch, None; Jodi Luchs, None; Gaston Lacayo, None; Gregg Berdy, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1517. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      William Trattler, Roy Rubinfeld, Gabriela Perez, John Talamo, Kathryn M. Hatch, Jodi Luchs, Gaston Lacayo, Gregg Berdy; Outcomes of Epithelium-On Crosslinking in Older Adults. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1517.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To evaluate patient outcomes following Epithelium-On CXL in patients over the age of 35.

Methods: : This prospective, non-randomized trial evaluated patients who underwent epithelial-ON CXL. A subgroup of patients over the age of 35 was evaluated for this analysis. Post-Op measures included corneal hysteresis (CH) and corneal resistance factor (CRF), Pentacam data, and uncorrected and best-spectacle corrected visual acuities. Eyes evaluated had a minimum follow-up visit of 3 months and a maximum follow up visit of 12.8 months.

Results: : 90 eyes met the entry criteria (65 male, 22 female), with a follow up range of 3 months minimum to 12.8 months maximum. The mean follow up was 7.9 months. 67% of these eyes had a pre-op diagnosis of keratoconus, 20% had post-LASIK Ectasia, and 3% had pellucid marginal degeneration. Average CH and CRF values increased post-Operatively from 7.7 to 8.0 and 6.5 to 8.0, respectively, at the latest follow up visit. Average refractive cylinder decreased from 4.59 D to 4.15D. On Pentacam the average 2mm K Astigmatism decreased from 5.94 to 4.71 and Holladay Astigmatism decreased from 3.31 to 2.26. 34.8% of eyes experienced no change in the number of lines of BSCVA and 46% of eyes gained 1 or more lines of BSCVA. Average BSCVA pre-Op was 20/163 and post-Op was 20/109.

Conclusions: : Epithelial-on cross-linking appears to be safe and effective for patients of age 35 and over with ectatic corneal disease.

Clinical Trial: : NCT01024322

Keywords: keratoconus 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.